Fairvalue-Calculator Fairvalue-Calculator
EN DE

Unicon Optical Co (4150) Fair Value & Analysis

Healthcare · TW · Market cap 746M TWD

Price4.95 TWD
Fair Value2.22 TWD
Upside-55.2%
Quality95/100
Evidence: Low Range 1.65 TWD – 3.31 TWD

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Unicon Optical Co (4150) currently trades at 4.95 TWD, while our model-based Fair Value estimate is 2.22 TWD — implying the stock looks roughly 55.2% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Unicon Optical Co., Ltd. researches, develops, designs, manufactures, and sells contact lenses in Taiwan. The company offers basic blue tint, color, and silicon hydrogel lenses under the brand name UNICON. The company was founded in 1992 and is headquartered in Hsinchu City, Taiwan.

Open the full interactive analysis →

Similar stocks

Intuitive Surgical, Inc (ISRG) -55% EssilorLuxottica Société anonyme (ESLOF) -34% HOYA Corporation (HOCPY) -42% Medline Inc (MDLN) -13% Becton, Dickinson and Company (BDX) -28% Alcon Inc (ALC) -33%

Frequently asked questions

Is Unicon Optical Co (4150) undervalued?
As of Jun 25, 2026, our model estimates a fair value of 2.22 TWD versus a price of 4.95 TWD — about −55% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 4150?
Our 21-model fair value for Unicon Optical Co is 2.22 TWD (as of Jun 25, 2026), built from audited fundamentals. The current price is 4.95 TWD.
What is the quality score of 4150?
Unicon Optical Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.